Important information about cancer drug benefits, and related uncertainties, is frequently omitted from official prescription drug information sources for clinicians and patients in Europe, finds an analysis published by The BMJ today.
from Medical Xpress - latest medical and health news stories https://ift.tt/XTetGBj
